Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43


Prevention and Early Detection for Non-Small Cell Lung Cancer: Advances in Thoracic Oncology 2018.

Balata H, Fong KM, Hendriks LE, Lam S, Ostroff JS, Peled N, Wu N, Aggarwal C.

J Thorac Oncol. 2019 Jun 19. pii: S1556-0864(19)30476-9. doi: 10.1016/j.jtho.2019.06.011. [Epub ahead of print] Review.


Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors.

Hendriks LEL, Bootsma G, Mourlanette J, Henon C, Mezquita L, Ferrara R, Audigier-Valette C, Mazieres J, Lefebvre C, Duchemann B, Cousin S, le Pechoux C, Botticella A, De Ruysscher D, Dingemans AC, Besse B.

Eur J Cancer. 2019 Jul;116:182-189. doi: 10.1016/j.ejca.2019.05.019. Epub 2019 Jun 13.


Defining synchronous oligometastatic non-small cell lung cancer: a systematic review.

GiajLevra N, Levra MG, Durieux V, Novello S, Besse B, Hasan B, Hendriks LE, Levy A, Dingemans AC, Berghmans T; European Organisation for Research and Treatment of Cancer-Lung Cancer Group (EORTC-LCG).

J Thorac Oncol. 2019 Jun 10. pii: S1556-0864(19)30458-7. doi: 10.1016/j.jtho.2019.05.037. [Epub ahead of print] Review.


Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study.

Schoenmaekers J, Hofman P, Bootsma G, Westenend M, de Booij M, Schreurs W, Houben R, De Ruysscher D, Dingemans AM, Hendriks LEL.

Eur J Cancer. 2019 Jul;115:88-96. doi: 10.1016/j.ejca.2019.04.017. Epub 2019 May 23.


Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study.

De Ruysscher D, van Baardwijk A, Wanders R, Hendriks LE, Reymen B, van Empt W, Öllers MC, Bootsma G, Pitz C, van Eijsden L, Dingemans AC.

Radiother Oncol. 2019 Jun;135:141-146. doi: 10.1016/j.radonc.2019.03.009. Epub 2019 Mar 27.


Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors.

Hendriks LEL, Henon C, Auclin E, Mezquita L, Ferrara R, Audigier-Valette C, Mazieres J, Lefebvre C, Rabeau A, Le Moulec S, Cousin S, Duchemann B, le Pechoux C, Botticella A, Ammari S, Gazzah A, Caramella C, Adam J, Lechapt E, Planchard D, De Ruysscher D, Dingemans AM, Besse B.

J Thorac Oncol. 2019 Jul;14(7):1244-1254. doi: 10.1016/j.jtho.2019.02.009. Epub 2019 Feb 16.


Is it time to incorporate surgery in the treatment of stage IV non-small cell lung cancer?

Hendriks LEL, Dingemans AC.

Lung Cancer. 2019 Mar;129:95-97. doi: 10.1016/j.lungcan.2019.01.011. Epub 2019 Jan 30. No abstract available.


Prospects of targeted and immune therapies in SCLC.

Hendriks LEL, Menis J, Reck M.

Expert Rev Anticancer Ther. 2019 Feb;19(2):151-167. doi: 10.1080/14737140.2019.1559057. Epub 2018 Dec 28.


Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapy.

Hendriks LE, Rouleau E, Besse B.

Transl Lung Cancer Res. 2018 Dec;7(6):647-660. doi: 10.21037/tlcr.2018.09.22. Review.


Editorial: Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment.

Hendriks LEL, Subramaniam DS, Dingemans AC.

Front Oncol. 2018 Nov 6;8:511. doi: 10.3389/fonc.2018.00511. eCollection 2018. No abstract available.


Responding to the challenges of international collaborations between the east and the west - report of the first JCOG-EORTC symposium and a perspective from young JCOG and EORTC investigators.

Kataoka K, Kaider-Person O, Kasper B, Starlinger P, Caballero C, Menis J, Hendriks LE, Terada M, Collette L, Nakamura K, Lacombe D, Fukuda H.

Jpn J Clin Oncol. 2019 Jan 1;49(1):96-99. doi: 10.1093/jjco/hyy155.


Immunotherapy for oncogenic-driven advanced non-small cell lung cancers: Is the time ripe for a change?

Remon J, Hendriks LE, Cabrera C, Reguart N, Besse B.

Cancer Treat Rev. 2018 Dec;71:47-58. doi: 10.1016/j.ctrv.2018.10.006. Epub 2018 Oct 15. Review.


Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer.

de Jong EEC, van Elmpt W, Rizzo S, Colarieti A, Spitaleri G, Leijenaar RTH, Jochems A, Hendriks LEL, Troost EGC, Reymen B, Dingemans AC, Lambin P.

Lung Cancer. 2018 Oct;124:6-11. doi: 10.1016/j.lungcan.2018.07.023. Epub 2018 Jul 20.


Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450).

De Ruysscher D, Wanders R, Hendriks LE, van Baardwijk A, Reymen B, Houben R, Bootsma G, Pitz C, van Eijsden L, Dingemans AC.

J Thorac Oncol. 2018 Dec;13(12):1958-1961. doi: 10.1016/j.jtho.2018.07.098. Epub 2018 Sep 22.


External validation of an NTCP model for acute esophageal toxicity in locally advanced NSCLC patients treated with intensity-modulated (chemo-)radiotherapy.

Dankers FJWM, Wijsman R, Troost EGC, Tissing-Tan CJA, Kwint MH, Belderbos J, de Ruysscher D, Hendriks LE, de Geus-Oei LF, Rodwell L, Dekker A, Monshouwer R, Hoffmann AL, Bussink J.

Radiother Oncol. 2018 Nov;129(2):249-256. doi: 10.1016/j.radonc.2018.07.021. Epub 2018 Sep 18.


Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer.

Arbour KC, Mezquita L, Long N, Rizvi H, Auclin E, Ni A, Martínez-Bernal G, Ferrara R, Lai WV, Hendriks LEL, Sabari JK, Caramella C, Plodkowski AJ, Halpenny D, Chaft JE, Planchard D, Riely GJ, Besse B, Hellmann MD.

J Clin Oncol. 2018 Oct 1;36(28):2872-2878. doi: 10.1200/JCO.2018.79.0006. Epub 2018 Aug 20.


Brain imaging in early stage non-small cell lung cancer: still a controversial topic?

Schoenmaekers JJAO, Dingemans AC, Hendriks LEL.

J Thorac Dis. 2018 Jul;10(Suppl 18):S2168-S2171. doi: 10.21037/jtd.2018.06.68. No abstract available.


The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation.

Witlox WJA, Ramaekers BLT, Zindler JD, Eekers DBP, van Loon JGM, Hendriks LEL, Dingemans AC, De Ruysscher DKM.

Front Oncol. 2018 Jul 26;8:241. doi: 10.3389/fonc.2018.00241. eCollection 2018. Review.


What you see is (not) what you get: tools for a non-radiologist to evaluate image quality in lung cancer.

de Jong EEC, Hendriks LEL, van Elmpt W, Gietema HA, Hofman PAM, De Ruysscher DKM, Dingemans AC.

Lung Cancer. 2018 Sep;123:112-115. doi: 10.1016/j.lungcan.2018.07.014. Epub 2018 Jul 18.


Invasive Aspergillosis Mimicking Metastatic Lung Cancer.

Vanfleteren MJEGW, Dingemans AC, Surmont VF, Vermaelen KY, Postma AA, Oude Lashof AML, Pitz CCM, Hendriks LEL.

Front Oncol. 2018 Jun 5;8:188. doi: 10.3389/fonc.2018.00188. eCollection 2018.


Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer.

Kuijpers CCHJ, Hendriks LEL, Derks JL, Dingemans AC, van Lindert ASR, van den Heuvel MM, Damhuis RA, Willems SM.

Lung Cancer. 2018 Jul;121:76-81. doi: 10.1016/j.lungcan.2018.05.006. Epub 2018 May 15.


Are We Ready to Safely Combine Anti-PD-1/PD-L1 with Cranial Irradiation in Non-Small Cell Lung Cancer Patients?

Levy A, Hendriks LE, Faivre-Finn C.

J Thorac Oncol. 2018 Apr;13(4):475-477. doi: 10.1016/j.jtho.2018.02.019. No abstract available.


Current perspective: Osimertinib-induced QT prolongation: new drugs with new side-effects need careful patient monitoring.

Schiefer M, Hendriks LEL, Dinh T, Lalji U, Dingemans AC.

Eur J Cancer. 2018 Mar;91:92-98. doi: 10.1016/j.ejca.2017.12.011. Review.


Heat shock protein antagonists in early stage clinical trials for NSCLC.

Hendriks LEL, Dingemans AC.

Expert Opin Investig Drugs. 2017 May;26(5):541-550. doi: 10.1080/13543784.2017.1302428. Epub 2017 Mar 8. Review.


Screening for Brain Metastases in Resectable Non-Small Cell Lung Cancer.

Hendriks LE, Hochstenbag M, Dingemans AM.

J Thorac Oncol. 2017 Mar;12(3):e21. doi: 10.1016/j.jtho.2016.11.2220. No abstract available.


Use of Systemic Therapy Concurrent With Cranial Radiotherapy for Cerebral Metastases of Solid Tumors.

Verduin M, Zindler JD, Martinussen HM, Jansen RL, Croes S, Hendriks LE, Eekers DB, Hoeben A.

Oncologist. 2017 Feb;22(2):222-235. doi: 10.1634/theoncologist.2016-0117. Epub 2017 Feb 6.


Management of stage I and II nonsmall cell lung cancer.

McDonald F, De Waele M, Hendriks LE, Faivre-Finn C, Dingemans AC, Van Schil PE.

Eur Respir J. 2017 Jan 3;49(1). pii: 1600764. doi: 10.1183/13993003.00764-2016. Print 2017 Jan. Review.


Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?

Hendriks LE, Brouns AJ, Amini M, Uyterlinde W, Wijsman R, Bussink J, Biesma B, Oei SB, Stigt JA, Bootsma GP, Belderbos JS, De Ruysscher DK, Van den Heuvel MM, Dingemans AC.

Lung Cancer. 2016 Nov;101:68-75. doi: 10.1016/j.lungcan.2016.09.008. Epub 2016 Sep 9.


Stage III Non-Small Cell Lung Cancer in the elderly: Patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice.

Driessen EJ, Bootsma GP, Hendriks LE, van den Berkmortel FW, Bogaarts BA, van Loon JG, Dingemans AC, Janssen-Heijnen ML.

Radiother Oncol. 2016 Oct;121(1):26-31. doi: 10.1016/j.radonc.2016.07.025. Epub 2016 Aug 10.


Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC.

Sanders KJ, Hendriks LE, Troost EG, Bootsma GP, Houben RM, Schols AM, Dingemans AM.

J Thorac Oncol. 2016 Jun;11(6):873-9. doi: 10.1016/j.jtho.2016.02.013. Epub 2016 Mar 3.


Proposals for the M-descriptors of the Eight TNM Classification for Non-Small Cell Lung Cancer: Are More Data Needed?

Hendriks LE, Dingemans AM, De Ruysscher D.

J Thorac Oncol. 2016 Mar;11(3):e42-3. doi: 10.1016/j.jtho.2015.11.013. No abstract available.


Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients with Non-Small Cell Lung Cancer and Bone Metastases: A Systematic Review.

Hendriks LE, Hermans BC, van den Beuken-van Everdingen MH, Hochstenbag MM, Dingemans AM.

J Thorac Oncol. 2016 Feb;11(2):155-73. doi: 10.1016/j.jtho.2015.10.001. Epub 2015 Dec 22. Review.


Clinical features of large cell neuroendocrine carcinoma: a population-based overview.

Derks JL, Hendriks LE, Buikhuisen WA, Groen HJ, Thunnissen E, van Suylen RJ, Houben R, Damhuis RA, Speel EJ, Dingemans AM.

Eur Respir J. 2016 Feb;47(2):615-24. doi: 10.1183/13993003.00618-2015. Epub 2015 Nov 5.


Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer.

Mellema WW, Masen-Poos L, Smit EF, Hendriks LE, Aerts JG, Termeer A, Goosens MJ, Smit HJ, van den Heuvel MM, van der Wekken AJ, Herder GJ, Krouwels FH, Stigt JA, van den Borne BE, Haitjema TJ, Staal-Van den Brekel AJ, van Heemst RC, Pouw E, Dingemans AM.

Lung Cancer. 2015 Nov;90(2):249-54. doi: 10.1016/j.lungcan.2015.09.012. Epub 2015 Sep 15.


Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.

Hendriks LE, Derks JL, Postmus PE, Damhuis RA, Houben RM, Troost EG, Hochstenbag MM, Smit EF, Dingemans AM.

Eur J Cancer. 2015 Nov;51(17):2534-44. doi: 10.1016/j.ejca.2015.08.008. Epub 2015 Aug 28.


Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.

Kuiper JL, Hendriks LE, van der Wekken AJ, de Langen AJ, Bahce I, Thunnissen E, Heideman DA, Berk Y, Buijs EJ, Speel EJ, Krouwels FH, Smit HJ, Groen HJ, Dingemans AM, Smit EF.

Lung Cancer. 2015 Sep;89(3):255-61. doi: 10.1016/j.lungcan.2015.05.023. Epub 2015 Jun 6.


Safety of cranial radiotherapy concurrent with tyrosine kinase inhibitors in non-small cell lung cancer patients: A systematic review.

Hendriks LE, Schoenmaekers J, Zindler JD, Eekers DB, Hoeben A, De Ruysscher DK, Dingemans AM.

Cancer Treat Rev. 2015 Jul;41(7):634-45. doi: 10.1016/j.ctrv.2015.05.005. Epub 2015 May 13. Review.


Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases.

Hendriks LE, Troost EG, Steward A, Bootsma GP, De Jaeger K, van den Borne BE, Dingemans AM.

Acta Oncol. 2014 Jul;53(7):945-51. doi: 10.3109/0284186X.2014.906746. Epub 2014 Apr 23.


EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?

Hendriks LE, Smit EF, Vosse BA, Mellema WW, Heideman DA, Bootsma GP, Westenend M, Pitz C, de Vries GJ, Houben R, Grünberg K, Bendek M, Speel EJ, Dingemans AM.

Lung Cancer. 2014 Apr;84(1):86-91. doi: 10.1016/j.lungcan.2014.01.006. Epub 2014 Jan 23.


Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?

Hendriks LE, Bootsma GP, de Ruysscher DK, Scheppers NA, Hofman PA, Brans BT, Dingemans AM.

Lung Cancer. 2013 Jun;80(3):293-7. doi: 10.1016/j.lungcan.2013.02.006. Epub 2013 Mar 18.


[A man with persisting dyspnea].

Hendriks LE, Gronenschild MH, van Haren EH.

Ned Tijdschr Geneeskd. 2013;157(3):A5158. Dutch.


Lung cancer in idiopathic pulmonary fibrosis patients diagnosed during or after lung transplantation.

Hendriks LE, Drent M, van Haren EH, Verschakelen JA, Verleden GM.

Respir Med Case Rep. 2012 Mar 17;5:37-9. doi: 10.1016/j.rmedc.2011.10.003. eCollection 2012.


Hyperthyroidism caused by excessive consumption of sausages.

Hendriks LE, Looij BJ.

Neth J Med. 2010 Mar;68(3):135-7.

Supplemental Content

Loading ...
Support Center